DBV712
V712-306 (VITESSE)
Phase 3 small_molecule active
Quick answer
DBV712 for Allergy, Peanut is a Phase 3 program (small_molecule) at DBV Technologies with 1 ClinicalTrials.gov record(s).
Program details
- Company
- DBV Technologies
- Indication
- Allergy, Peanut
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active